|
|
| U.S. Nuclear
Power Reactor Map
iOSAT™
received its approval from the US Food and Drug Administration in 1982,
and is the only full-strength tablet for radiation blocking which may
legally be sold in the US. Only iOSAT™ has passed all FDA tests for purity, quality, safety and efficacy.
Meets all FDA requirements
for potassium iodide as a radiation protective, and is labeled and packaged
in accordance with US government guidelines.
Has demonstrated all quality controls and passed all FDA requirements
for purity, quality, safety, efficacy.
Comes full strength (130
mg of potassium iodide per tablet) in accordance with FDA demands for complete
thyroid blocking.
|
|
|
|
|
Note that we are unable to officially promote or endorse
IOSAT for the protection of pets since our approved labeling by the FDA does not
cover this.
However, thyroid function in many animals is very similar to
humans, so, unofficially, we are very confident the product would prove to be
safe and effective. For pets under 25 lbs, we would recommend 1/4 tablet for
dosing in a radiation emergency. For pets from 25 to 150 lbs., we would
recommend 1/2 tablet.
Most important, though, is that we would recommend that
any questions be addressed to a qualified veterinarian.
|
|
|
|
| U.S. Power Reactor
Radiation Zones
Contains no potassium iodate
or other adulterants. Contains only pure potassium iodide as the active
ingredient.
IOSAT [potassium iodide]
Is manufactured in the United States under strict FDA GMP guidelines,
and
holds an approved New Drug Application (NDA).
IOSAT [potassium iodide]
Was the first product of its kind (since 1982) and is the only product that
can be purchased by local, state and federal governments.
Is widely purchased by nuclear utilities.
IOSAT [potassium iodide]
offers unit dose packaging for maximum shelf-life and allows for individual
tablet distribution without fear of loss of packaging integrity.
|
|
|